EC Number   |
Protein Variants |
Reference |
|---|
   3.4.22.B30 | more |
a 111/112-haplotype combination created by the Calpain-10 single nucleotide polymorphisms 43, 19, and 63 is associated with risk of type 2 diabetes mellitus in the east Indian population |
708286 |
| 3.4.22.B30 | more |
CAPN10 polymorphisms occur in the development of type 2 diabetes mellitus, ariation in the CAPN10 gene (SNP-43 G/G, InDel-19 3/2 and SNP-63 C/T) known as haplotype 121/112 |
731226 |
| 3.4.22.B30 | more |
CAPN10 UCSNP-19 single nucleotide polymorphisms and haplotype 111 contribute to the risk of type 2 diabetes in Tunisian subjects. There is no significant association between CAPN10 diplotypes and type 2 diabetes |
708288 |
| 3.4.22.B30 | more |
CAPN10 UCSNP-19 variant, and the 111 haplotype (UCSNP-43/UCSNP-19/UCSNP-63) contribute to the risk of type 2 diabetes in Tunisian subjects. No significant associations between CAPN10 diplotypes and type 2 diabetes are demonstrated for Tunisians |
707886 |
| 3.4.22.B30 | more |
CAPN10 UCSNP-63 genotype 12 is related with a worse prognosis in laryngeal cancer |
708636 |
| 3.4.22.B30 | more |
siRNA-mediated knockdown of calpain-10 |
731722 |
| 3.4.22.B30 | more |
the rs2953171 polymorphism at the CAPN10 gene locus influences insulin sensitivity by interacting with the plasma fatty acid composition in subjects with metabolic syndrome |
717063 |
